12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Io Therapeutics preclinical data

In a mouse model of AD, short-term treatment with IRX4204 significantly improved cognitive function as measured by the Morris Water Maze test and a contextual...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >